المؤلفون: Petrillo A, Tirino G, Zito Marino F, Pompella L, Sabetta R, Panarese I, Pappalardo A, Caterino M, Ventriglia A, Laterza MM, Morgillo F, Orditura M, Ciardiello F, Franco R, De Vita F

المصدر: OncoTargets and Therapy, Vol Volume 13, Pp 867-876 (2020)

مصطلحات موضوعية: immune-checkpoint inhibitors, nivolumab, immunotherapy, third line, pd-l1, msi, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/nivolumab-in-heavily-pretreated-metastatic-gastric-cancer-patients-rea-peer-reviewed-article-OTTTest; https://doaj.org/toc/1178-6930Test

الوصول الحر: https://doaj.org/article/e21c61e06e134effab673c8c0810d538Test

المؤلفون: Petrillo A., Tirino G., Marino F. Z., Pompella L., Sabetta R., Panarese I., Pappalardo A., Caterino M., Ventriglia A., Laterza M. M., Morgillo F., Orditura M., Ciardiello F., Franco R., De Vita F., ZITO MARINO, Federica

المساهمون: Petrillo, A., Tirino, G., Marino, F. Z., Pompella, L., Sabetta, R., Panarese, I., Pappalardo, A., Caterino, M., Ventriglia, A., Laterza, M. M., Morgillo, F., Orditura, M., Ciardiello, F., Franco, R., De Vita, F., ZITO MARINO, Federica

المصدر: OncoTargets and therapy

مصطلحات موضوعية: nivolumab, PD-L1, Immune-checkpoint inhibitor, immune-checkpoint inhibitors, immunotherapy, third line, MSI, Original Research

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::824eda5978d38faab64a80b80dea3affTest
https://pubmed.ncbi.nlm.nih.gov/32099391Test